Plaque Psoriasis
📧 Sign up to get email alerts when something new happens for Plaque Psoriasis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2026-04-20Clinical Trial Update: Long-Term Safety Study of Deucravacitinib Versus Ustekinumab in Participants With Psoriasis (PRAGMATYK) [Phase 3]
Phase 3 long-term safety study comparing deucravacitinib with ustekinumab in adults with plaque psoriasis is currently recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-20Clinical Trial Update: Bimekizumab in Plaque Psoriasis [Phase 4]
A Phase 4 clinical trial evaluating bimekizumab for plaque psoriasis has completed.
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: A Study to Investigate the Effectiveness of Tirzepatide (LY3298176) Following Initiation of Ixekizumab (LY2439821) in Participants With Moderate-to-Severe Plaque PsO and Obesity or Overweight in Clinical Practice (TOGETHER AMPLIFY-PsO) [Phase 4]
Phase 4 clinical trial evaluating the effectiveness of tirzepatide after initiating ixekizumab in adults with moderate-to-severe plaque psor…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Tapinarof for the Treatment of Plaque Psoriasis in Pediatric Subjects [Phase 3]
Phase 3 trial update for tapinarof in pediatric plaque psoriasis; the study is active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: Study to Assess Change in Quality of Life of Risankizumab Treatment in Adult Participants With Moderate-to-Severe Plaque Psoriasis
This clinical trial registry entry describes a study to evaluate changes in quality of life for adults with moderate-to-severe plaque psoria…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-16Clinical Trial Update: A Study to Evaluate Comparative Efficacy and Safety of Guselkumab in High-dose and Extended-interval Versus Standard-dose in Chinese Participants of Moderate-to-severe Plaque Psoriasis [NA]
This clinical trial is evaluating high-dose and extended-interval guselkumab regimens compared with standard-dose in Chinese participants wi…
-
FDA approval · 2026-04-15FDA Approved: USTEKINUMAB — Supplemental Application (Janssen Biotech, Inc.)
FDA approved a supplemental application for ustekinumab submitted by Janssen Biotech, Inc. The action pertains to a supplemental submission …
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: A Study to Learn How Safe and Effective Risankizumab is When Compared to Deucravacitinib to Treat Participants With Moderate Plaque Psoriasis and Who Need to Try Systemic Treatment (Works Throughout the Whole Body) [Phase 4]
A Phase 4 head-to-head trial comparing risankizumab with deucravacitinib in moderate plaque psoriasis has completed, aiming to compare safet…
-
CLINICAL_TRIALS trial_result · 2026-04-15Clinical Trial Update: To Evaluate the Efficacy and Safety of Netakimab in Chinese Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 study evaluating the efficacy and safety of netakimab in Chinese patients with moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Observational Study to Evaluate Deucravacitinib in Patients With Moderate Plaque Psoriasis in China
An observational study in China evaluating Deucravacitinib for moderate plaque psoriasis; the trial is currently active but not recruiting.
-
CLINICAL_TRIALS research · 2026-04-15Clinical Trial Update: A Study of Tildrakizumab in Pediatric Subjects With Chronic Plaque Psoriasis [Phase 2, Phase 3]
This update reports a pediatric Phase 2/3 study of tildrakizumab for chronic plaque psoriasis, which is currently active but not recruiting.
-
CLINICAL_TRIALS trial_result · 2026-04-14Clinical Trial Update: A Clinical Trail of Adalimumab in Treating Chinese Children With Severe Plaque Psoriasis [Phase 4]
This document describes a Phase 4 clinical trial evaluating adalimumab for severe plaque psoriasis in Chinese children, which has not yet st…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of ESK-001 in Patients With Moderate to Severe Plaque Psoriasis [Phase 3]
This clinical trial update reports the Phase 3 study of ESK-001 evaluating its efficacy and safety in patients with moderate to severe plaqu…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: Long-term Safety and Efficacy of ESK-001 in Moderate to Severe Plaque Psoriasis [Phase 3]
This Phase 3 trial update presents long-term safety and efficacy data for ESK-001 in adults with moderate-to-severe plaque psoriasis; the st…
-
CLINICAL_TRIALS trial_result · 2026-04-13Clinical Trial Update: A Study in Patients With Moderate to Severe Plaque Psoriasis to Evaluate the Efficacy and Safety of ESK-001 [Phase 3]
Phase 3 study evaluating ESK-001 for moderate to severe plaque psoriasis has completed.
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Assess Efficacy and Safety of JNJ-77242113 Compared to Placebo and Ustekinumab in Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
A Phase 3 clinical trial update on JNJ-77242113 comparing it with placebo and ustekinumab in adults with moderate to severe plaque psoriasis…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study to Evaluate the Efficacy and Safety of Bimekizumab Compared to Ustekinumab in Children and Adolescents From 6 Years to Less Than 18 Years of Age With Moderate to Severe Plaque Psoriasis [Phase 3]
This Phase 3 clinical trial compares the efficacy and safety of bimekizumab versus ustekinumab in children and adolescents aged 6 to under 1…
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Study of JNJ-77242113 in Adolescent and Adult Participants With Moderate to Severe Plaque Psoriasis [Phase 3]
Phase 3 clinical trial update for JNJ-77242113 in adolescents and adults with moderate to severe plaque psoriasis, currently active but not …
-
CLINICAL_TRIALS research · 2026-04-13Clinical Trial Update: A Safety Study of Ustekinumab in the Treatment of Pediatric Participants Aged 6 Years and Older With Moderate to Severe Plaque Psoriasis
This clinical trial update indicates that Janssen-Cilag International NV's safety study of ustekinumab in pediatric participants aged 6 year…
-
CLINICAL_TRIALS trial_result · 2026-04-09Clinical Trial Update: A Safety and Pharmacokinetics Study of IDP-118 Lotion in Pediatric Participants With Plaque Psoriasis [Phase 4]
Phase 4 safety and pharmacokinetics study evaluating IDP-118 Lotion in pediatric participants with plaque psoriasis has been completed.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Phase 3 Clinical Study of QL2106 Injection [Phase 3]
A Phase 3 clinical study of QL2106 Injection for plaque psoriasis is listed as not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-06Clinical Trial Update: A Long-Term Study of Zasocitinib in Children and Teenagers With Plaque Psoriasis [Phase 3]
A Phase 3 long-term study of Zasocitinib in children and teenagers with plaque psoriasis is currently recruiting. The sponsor is Takeda.
-
CLINICAL_TRIALS trial_result · 2026-04-01Clinical Trial Update: Open-Label Extension Study to Evaluate the Long Term Safety and Efficacy of ESK-001 in Plaque Psoriasis [Phase 2]
Open-label extension study to assess long-term safety and efficacy of ESK-001 in plaque psoriasis (Phase 2).
-
CLINICAL_TRIALS trial_result · 2026-03-30Clinical Trial Update: Guselkumab Immunogenetics [Phase 4]
Phase 4 clinical trial update for guselkumab investigating immunogenetics in psoriasis, including guttate and plaque psoriasis, currently no…
-
CLINICAL_TRIALS research · 2026-03-30Clinical Trial Update: Collection of Samples From Subjects With Various Skin Conditions and Healthy Volunteers
Clinical trial update notes ongoing sample collection from participants with acne, atopic dermatitis, chronic hand eczema, hidradenitis supp…